@article{c49bdfebb48341d38d5942003793a704,
title = "Genetics: A new clinical tool for the hepatologist",
author = "Luca Valenti and Luisa Ronzoni",
note = "Funding Information: LV has received speaking fees from MSD, Gilead, AlfaSigma and AbbVie, served as a consultant for Gilead, Pfizer, AstraZeneca, Novo Nordisk, Intercept, Diatech Pharmacogenetics and Ionis Pharmaceuticals and received research grants from Gilead. Funding Information: Italian Ministry of Health (Ministero della Salute), Ricerca Finalizzata RF-2016-02364358 (?Impact of WES on the clinical management of patients with advanced nonalcoholic fatty liver and cryptogenic liver disease?), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Ricerca Corrente. Fondazione IRCCS Ca' Granda ?Liver BIBLE? (PR-0391) (LV).",
year = "2022",
month = apr,
doi = "10.1111/liv.15205",
language = "English",
volume = "42",
pages = "724--726",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "4",
}